by Joseph Peuskens, Jitendra Trivedi, Sergiy Malyarov, Martin Brecher, Ola Svensson, Frank Miller, Inger Persson, and Didier Meulien on behalf of the Study D1444C00004 investigators

Dr. Peuskens is with Universitair Psychiatrisch Centrum KU Leuven, Campus St Jozef Kortenberg, Belgium; Dr. Trivedi is with King George Medical University, Lucknow, India; Dr. Malyarov is with Kyiv Psychoneurological Hospital, Kyiv, Ukraine; Dr. Brecher is with AstraZeneca Pharmaceuticals, Wilmington, Delaware, US; and Drs. Svensson, Miller, Persson, and Meulien are with AstraZeneca Research and Development in Södertälje, Sweden.

Read the rest of this article »

Read the rest of this article »

by Timothy W. Fong, MD; and John Tsuang MD, MS

Dr. Fong is with the David Geffen School of Medicine at UCLA, Semel Institute of Neuroscience and Behavior, Department of Psychiatry and Biobehavioral Sciences, Assistant Clinical Professor, Director of the Impulse Control Disorders Clinic, and Co-Director of the UCLA Gambling Studies Program, Los Angeles, California; and Dr. Tsuang is Clinical Professor, Department of Psychiatry, University of California, Los Angeles, and Director of Dual Diagnostic Treatment Program, Harbor-UCLA Medical Center.

Read the rest of this article »

by Randy A. Sansone, MD; Lori A. Sansone, MD

Dr. R. Sansone is a Professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio, and Director of Psychiatry Education at Kettering Medical Center in Kettering, Ohio; Dr. L. Sansone is a civilian family medicine physician at Wright-Patterson Air Force Base in Dayton, Ohio.

Read the rest of this article »

by Ann Morrison, MD; and Beth McIlduff, MD

Dr. Morrison is Associate Professor of Psychiatry, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Dr. McIlduff is a first-year resident in psychiatry at Northwestern, University in Chicago, Illinois; and Dr. Gillig is Professor of Psychiatry, Boonshoft School of Medicine. Wright State University, Dayton, Ohio.

Read the rest of this article »

by Elisa F. Cascade; Amir H. Kalali, MD; and Pierre Blier, MD, PhD

Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Blier is a Professor of Psychiatry and Cellular and Molecular Medicine, University of Ottawa, Canada Research Chair, Psychopharmacology, Endowed Chair and Director, Mood Disorders Research Unit, Institute of Mental Health Research, Ottawa, Canada.

Read the rest of this article »

by Andrew A. Nierenberg, MD; and Steven D. Targum, MD

Dr. Targum is on the editorial board of Psychiatry 2007. Presently, he is Chief Medical Officer at Brain Cells Inc., an executive-in-residence at Oxford BioScience Partners, and a consultant in psychiatry at the Massachusetts General Hospital, Boston, Massachusetts; and Dr. Nierenberg is Director, Bipolar Trials Network, Medical Director, Bipolar Clinic and Research Program, Associate Director, Depression Clinical Reserach Program, and Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Read the rest of this article »

by Ahmed Aboraya, MD, DrPh

Dr. Aboraya is Clinical Associate Professor of Psychiatry at West Virginia School of Osteopathic Medicine, Director of the Young Adults Program at William R. Sharpe Jr. Hospital, and Director of the World Health Oganization (WHO) SCAN Training and Reference Center at West Virginia University, Morgantown, West Virginia.

Read the rest of this article »